Pathogenic variants and SNPs of the methylenetetrahydrofolate reductase (MTHFR) gene have been consistently reported in diseases present with cognitive impairment, such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and cerebrovascular lesions [48,49,50,51]. This evidence concerns the gene MTHFR and early-onset autosomal dominant Alzheimer disease.